Epidemiology of Gonococcal Arthritis (EpGAr)

Launched by UNIVERSITY HOSPITAL, BREST · Mar 20, 2025

Keywords

ClinConnect Summary

The Epidemiology of Gonococcal Arthritis (EpGAr) trial is designed to study a specific type of arthritis caused by a bacterial infection called Neisseria gonorrhoeae, which is often associated with gonorrhea. Over the past ten years, researchers at Brest and Rennes university hospitals have been looking into how common this infection is and what factors might put someone at risk for developing arthritis from it. They’re also interested in understanding the different types of bacteria involved and whether there are any common traits among them that could explain why some individuals get sick.

To be eligible for this study, participants need to have a joint sample that tests positive for Neisseria gonorrhoeae taken between 2014 and 2024. Unfortunately, those with a negative test result or who do not wish to participate cannot join. If you qualify and choose to take part, you can expect to contribute data that will help researchers better understand this infection and its effects. The insights gained from this study could ultimately improve treatment and prevention strategies for gonococcal arthritis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a Neisseria gonorrhoeae-positive joint sample (from an enrichment vial or a native sample) between 2014 and 2024.
• Exclusion Criteria:
• • Patients with Neisseria gonorrhoeae-negative joint sample (from enrichment vial or native sample).
• • Patients who have expressed opposition to inclusion in the study.
• • Patients under legal protection (guardianship, curatorship, etc.).